Abstract
Recently, monoclonal antibody techniques have provided an opportunity to reevaluate the role of nuclear medicine for the diagnosis of malignant diseases by using the immunological approach. The pioneering studies of Köhler and Milstein [1] made it possible to prepare in vitro immortal cell lines by means of the chemically mediated fusion of lymphocytes from immunized mice and cells from a mouse myeloma tumor. Cloned hybrid cells produce individual monoclonal antibodies in a continuous and virtually endless supply with extremely precise specificity and uniform reaction. To obtain greater specificity in the interpretation of neoplastic masses by in vivo methods, the immunological approach appears to be most promising. About 90 years ago the first attempt to use antibodies produced against malignant tissues was reported by Hericourt and Richet [2]. They prepared antiserum against human osteogenic sarcoma and observed that these sera were effective in the treatment of a fibrosarcoma and a gastric cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495
Hericourt J, Richet C (1895) Traitment d’un cas de sarcome par la sérotherapie. CR Hebd Seances Acad Sci 120:948
Behring v E, Kitasato S (1890) Dtsch Med Wschr 49:1113
Jerne NK, Nordin AA (1963) Plaque formation in agar by single antibody-producing cells. Science 140:405
Edelmann GM (1973) Antikörperstruktur und molekulare Immunologie. Angew Chem 85:1083
Porter RR (1973) Strukturuntersuchungen an Immunglobulinen. Angew Chem 85:1097
Pressman D, Keighley G (1948) The zone of activity of antibodies as determined by the use of radioactive tracers; the zone of a activity of nephrotoxic antikidney serum. J Immunol 59:141
Korngold L, Pressman D (1954) The localization of antilymphosarcoma antibodies in the Murphy lymphosarcoma of the rat. Cancer Res 14:96
Bale WF, Spar IL, Goodland RL (1960) Experimental radiation therapy of tumor with I -131-carrying antibodies to fibrin. Cancer Res 20:1488
Gold P, Freedman SO (1965) Demonstration of tumor specific antigens in human colonic carcinoma by immunological and adsorption technique. J Exp Med 21:439
Mach J-P, Carrel S, Merenda C, Sordat B, Cerottoni J-C (1974) In vivo localization of radiolabeled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature 248:704
Goldenberg DM, Preston DF, Primus FJ, Hansen HJ (1974) Photoscan localization of GW-39 tumors in hamsters using radiolabeled anti-carcinoembryonic antigen immunoglobulin G. Cancer Res. 34:1
Primus FJ, Wang RH, Goldenberg DM, Hansen HJ (1973) Localization of human GW-39 tumors in hamsters by radiolabeled heterospecific antibody to carcinoembryonic antigen. Cancer Res 33:2977
Hoffer PB, Lathrop K, Bekerman G, Fang VS, Refetoff S (1974) Use of 131I-CEA antibody as a tumor scanning agent. J Nucl Med 15:323
Mach J-P, Carrell S, Forni M, Ritschard J, Donath A, Alberto P (1980) Tumor localization of radiolabeled antibodies against carcinoembryonic antigen in patients with carcinoma. A critical evaluation. N Engl J Med 303:5
Goldenberg DM, DeLand F, Kim EE, Bennett S, Primus FJ, van Nagell JR, Estes N, De Simone P, Rayburn P (1978) Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298:1384
Mach J-P, Forni M, Ritschard J, Buchegger F, Carrel S, Wildgren S, Donath A, Alberto P (1980) Use and limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas. Oncodev Biol Med 1:49
Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Führer P (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somatic Cell Genet 5:957
Koprowski H, Herlyn M, Steplewski Z, Sears HF (1981) Specific antigen in serum of patients with colon carcinoma. Science 212:53
Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blasczyk M, Mitchell KF, Steplewski Z, Koprowski H (1981) A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212:55
Del Villano BC, Brennan S, Brock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski VR jr (1983) Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9. Clin Chem 29:549
Herlyn DM, Steplewski Z, Herlyn MF, Koprowski H (1980) Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res 40:717
Chatal J-F, Saccavini JC, Fumoleau P, Douillard J-Y, Curtet C, Kremer M, Le Mevel B, Koprowski H (1984) Immunoscintigraphy of colon carcinoma. J Nucl Med 25:307
Mach J-P, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso J-D, Schreyer M, Girardet C, Accolla RS, Carrel S (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunol Today 2:239
Wahl LR, Parker CW, Philpott GW (1983) Improved radioimaging and tumor localization with monoclonal F (ab′)2.J Nucl Med 24:316
Lorenz M, Maul FD, Hottenrott C, Encke A, Happ J (1985) CA 19-9 im Vergleich zu CEA in der Diagnostik gastrointestinaler Tumoren in der Chirurgie. In: Greten H, Klapdor R (eds) Neue tumorassoziierte Antigene — 2 Jahre klinische Erfahrung mit monoklonalen Antikörpern. Thieme, Stuttgart, p 332
Lorenz M, Happ J, Reimann-Kirkowa M, Hottenrott C, Maul FD, Encke A, Hör G (1985) CA 19-9 im Vergleich mit CEA in der chirurgischen Primär- und Rezidivdiagnostik. In: Greten H, Klapdor R (eds) Neue tumorassoziierte Antigene-2 Jahre klinische Erfahrung mit monoklonalen Antikörpern. Thieme, Stuttgart, p 95
Lorenz M, Hottenrott C, Happ J, Reimann-Kirkowa M, Maul FD, Encke A, Hör G (1985) CEA und CA 19-9 als Verlaufsparameter bei der intraarteriellen Therapie von Lebermetastasen. In: Greten H, Klapdor R (eds) Neue tumorassoziierte Antigene — 2 Jahre klimische Erfahrung mit monoklonalen Antikörpern. Thieme, Stuttgart, p 112
Mach J-P (1985) Personal communication
Berche C, Mach JP, Lumbroso JD, Langlais C, Aubry F, Buchegger F, Carrel S, Rougier P, Parmentier C, Tubiana M (1982) Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Brit Med J 285:1447
Senekowitsch R, Maul FD, Wenisch HJC, Kriegel H, Hör G (1985) Immunoscintigraphy of human pancreatic carcinoma in nude mice with I-131-F (ab′)2-fragments of monoclonal antibodies. J Nucl Med 26:P110
Senekowitsch R, Maul FD, Baum RP, Wenisch HJC, Schneidereit M, Moellenstaedt S, Kriegel H, Hör G (1985) Radioimmunoscintigraphy and immunohistochemical detection of different antigens in human pancreatic carcinoma xenografts with monoclonal antibodies. European Nuclear Medicine Congress, London (in press)
Baum RP, Maul FD, Lorenz M, Hottenrott C, Senekowitsch R, Happ J, Brandhorst I, Reimann-Kirkowa M, Encke A, Hör G (1985) Immunoscintigraphy with anti-CA 19-9/CEA monoclonal antibodies: follow-up of liver metastases (colonic cancer) before/after regional intraarterial treatment. Nucl Med Commun 6:597
Baum RP, Maul FD, Klapdor R, Senekowitsch R, Lorenz M, Hottenrott C, Montz R, Happ J, Kriegel H, Chatal JF, Hör G (1985) Immunszintigraphie kolorektaler Tumoren mit 131J-markierten monoklonalen Antikörpern (19-9/Anti-CEA): Erste Ergebnisse. Nuc Compact 16:121
Chatal J-F, Fumoleau P, Kremer M (1985) Complementary roles of immunoscintigraphy and ultrasonography. Eur J Nucl Med 10:464
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Baum, R.P. et al. (1986). Radioimmunoscintigraphy of CA 19-9/CEA Producing Tumors Using I-131 Labeled F(ab′)2 Fragments of Monoclonal Antibodies (19-9/Anti-CEA Radioimmunococktail). In: Winkler, C. (eds) Nuclear Medicine in Clinical Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70947-0_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-70947-0_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-16164-6
Online ISBN: 978-3-642-70947-0
eBook Packages: Springer Book Archive